Oragenics Stock Price

-0.0052 (-1.11%)
Volume 2,013
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Oragenics Inc OGEN AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0052 -1.11% 0.465 04:27:53
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
8 2,013 - 0.4318 - 1.80
Last Trade Time Type Quantity Stock Price Currency
04:34:17 3 $ 0.465 USD


Draw Mode:

Oragenics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 54.12M 116.39M 114.67M $ - $ - -0.48 -2.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 525.00k 6.00%

more financials information »

Oragenics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.50350.5340.460.495427837,178-0.0385-7.65%
1 Month0.51410.59440.4320.50689682,906,366-0.0491-9.55%
3 Months0.680.76990.43180.57940973,312,327-0.215-31.62%
6 Months0.57051.150.43180.71213494,659,292-0.1055-18.49%
1 Year0.951.800.43180.94947186,323,215-0.485-51.05%
3 Years0.972.120.260.84851775,059,398-0.505-52.06%
5 Years6.4448.500.260.96667593,585,908-5.98-92.78%

Oragenics Description

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and have other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering. It is also developing Terra CoV-2 immunization product candidate to combat the novel coronavirus.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.